L3VLUP
ProSign in

CVS in the 13F filings

CVS Health Corp · CUSIP 126650100

Sector · Consumer staples
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2025
the date the book describes
Filed
14 Nov 2025
latest of these filings; the earliest 12 Nov 2025
Managers listing it
28
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q2 2025 and Q3 2025; 25 listed it in both
Shares listed
291,132,985
combined, among listed positions
Reported value
$21.9bn
combined, at the quarter end

Among the 95 comparable managers: 16 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing CVS in Q3 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

28 of 28 holders

ActionFiling
Dodge & Cox73,176,586$5.5bn2.98%Trimmed-112,18013 Nov 2025 (the filing on sec.gov)
Capital World Investors68,382,158$5.2bn0.70%Added+1,419,57513 Nov 2025 (the filing on sec.gov)
Fidelity (FMR LLC)43,335,261$3.3bn0.17%Trimmed-2,274,96913 Nov 2025 (the filing on sec.gov)
Invesco Ltd24,293,058$1.8bn0.29%Added+760,57913 Nov 2025 (the filing on sec.gov)
T. Rowe Price Associates Inc17,397,735$1.3bn0.14%Added+784,59114 Nov 2025 (the filing on sec.gov)
Capital Research Global Investors11,469,250$865m0.16%Added+2,253,53113 Nov 2025 (the filing on sec.gov)
Glenview Capital Management LLC8,196,799$618m13.76%Held014 Nov 2025 (the filing on sec.gov)
Wellington Management Group LLP6,330,717$477m0.08%Addedn.a.14 Nov 2025 (the filing on sec.gov)
Millennium Management LLC5,378,148$405m0.17%Added+1,311,47814 Nov 2025 (the filing on sec.gov)
Arrowstreet Capital LP5,294,134$399m0.25%Added+2,188,30713 Nov 2025 (the filing on sec.gov)
Marshall Wace LLP3,664,700$276m0.28%Added+1,930,50513 Nov 2025 (the filing on sec.gov)
Janus Henderson Group Ltd3,370,475$254m0.12%Added+354,81214 Nov 2025 (the filing on sec.gov)
Citadel Advisors LLC3,217,177$243munder 0.1%Trimmed-4,959,38314 Nov 2025 (the filing on sec.gov)
Sachem Head Capital Management LP3,150,000$237m6.71%Added+130,00014 Nov 2025 (the filing on sec.gov)
AQR Capital Management LLC3,052,839$230m0.15%Added+774,03214 Nov 2025 (the filing on sec.gov)
Squarepoint Ops LLC1,816,239$137m0.14%Added+275,76914 Nov 2025 (the filing on sec.gov)
Holocene Advisors LP1,668,227$126m0.29%Trimmed-705,71514 Nov 2025 (the filing on sec.gov)
AllianceBernstein LP1,442,116$109munder 0.1%Trimmed-167,28814 Nov 2025 (the filing on sec.gov)
Freestone Grove Partners LP1,246,322$94m0.70%Trimmed-1,21614 Nov 2025 (the filing on sec.gov)
Bridgewater Associates LP1,193,144$90m0.35%Added+356,55613 Nov 2025 (the filing on sec.gov)
D. E. Shaw & Co.1,118,143$84munder 0.1%Added+190,78614 Nov 2025 (the filing on sec.gov)
Woodline Partners LP701,748$53m0.25%Trimmed-261,48514 Nov 2025 (the filing on sec.gov)
Man Group PLC623,534$47m0.08%Trimmed-902,47814 Nov 2025 (the filing on sec.gov)
Harris Associates LP548,572$41m0.07%Trimmed-295,47714 Nov 2025 (the filing on sec.gov)
Point72 Asset Management LP426,087$32m0.05%Newnew14 Nov 2025 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q2 2025 to Q3 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
31 in Q3 2024 to 31 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CVS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201319$12.0bnn.a.n.a.
Q3 201322$11.8bnn.a.n.a.
Q4 201319$14.0bnn.a.n.a.
Q1 201417$15.3bnn.a.n.a.
Q2 201424$14.7bnn.a.n.a.
Q3 201421$15.4bnn.a.n.a.
Q4 201424$18.3bnn.a.n.a.
Q1 201525$19.7bnn.a.n.a.
Q2 201524$20.2bnn.a.n.a.
Q3 201530$19.0bnn.a.n.a.
Q4 201525$17.8bnn.a.n.a.
Q1 201624$17.1bnn.a.n.a.
Q2 201634$14.3bnn.a.n.a.
Q3 201630$12.8bnn.a.n.a.
Q4 201632$9.3bnn.a.n.a.
Q1 201729$8.7bnn.a.n.a.
Q2 201720$9.0bnn.a.n.a.
Q3 201723$9.4bnn.a.n.a.
Q4 201732$10.5bnn.a.n.a.
Q1 201831$8.7bnn.a.n.a.
Q2 201821$8.1bnn.a.n.a.
Q3 201825$10.7bnn.a.n.a.
Q4 201833$11.4bnn.a.n.a.
Q1 201927$8.5bnn.a.n.a.
Q2 201925$8.0bnn.a.n.a.
Q3 201925$9.6bnn.a.n.a.
Q4 201927$11.4bnn.a.n.a.
Q1 202029$8.1bnn.a.n.a.
Q2 202026$9.3bnn.a.n.a.
Q3 202029$8.9bnn.a.n.a.
Q4 202022$9.8bnn.a.n.a.
Q1 202128$10.3bnn.a.n.a.
Q2 202124$11.8bnn.a.n.a.
Q3 202128$11.9bnn.a.n.a.
Q4 202128$14.7bnn.a.n.a.
Q1 202225$14.4bnn.a.n.a.
Q2 202230$13.5bnn.a.n.a.
Q3 202228$13.9bnn.a.n.a.
Q4 202230$12.6bnn.a.n.a.
Q1 202336$9.6bnn.a.n.a.
Q2 202333$9.8bnn.a.n.a.
Q3 202333$11.7bnn.a.n.a.
Q4 202332$14.2bn1518
Q1 202421$14.3bn914
Q2 202424$14.2bn168
Q3 202431$14.2bn2310
Q4 202432$11.0bn1716
Q1 202529$19.1bn2010
Q2 202531$19.6bn1912
Q3 202528$21.9bn1611
Q4 202529$22.8bn1823
Q1 202632$21.1bn2420
Q2 202631$30.8bn1824

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CVS and PM →CVS and KO →CVS and COST →Choose a stock to compare with CVS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CVS, latest filings →Back to the 13F Explorer →